Stay updated on Pimavanserin Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Relapse Prevention Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision label (v3.5.5) appears in the study record history, replacing the previous label (v3.5.4), indicating a minor metadata update to the page. This change does not alter the study data.
    Difference
    0.1%
    Check dated 2026-06-05T13:30:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, appears in the Record History, replacing the previous v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T02:09:08.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The bottom of the page now shows Revision: v3.5.3, replacing v3.5.2. This indicates an updated page build/version.
    Difference
    0.1%
    Check dated 2026-04-30T17:25:40.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.2 and removes v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:36:54.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a new record version v3.5.0 to the history; the previous v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:06:18.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision v3.4.3 added to the history; revision v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:57:55.000Z thumbnail image

Stay in the know with updates to Pimavanserin Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Relapse Prevention Clinical Trial page.